Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    9647875 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated ACVBP Versus ACVBP Plus Rituximab in Low Risk Localized Diffuse Large B-cell Lymphoma
Condition: Diffuse Large Cell Lymphoma
Intervention: Drug: rituximab

Study has passed its completion date and status has not been verified in more than two years.